Correspondence 0001104659-23-023962 from Fisher Wallace Laboratories, Inc. (CIK 0001787792)
Fisher Wallace Laboratories, Inc. (CIK 0001787792)
Date: Feb. 22, 2023 · CIK: 0001787792 · Accession: 0001104659-23-023962
AI Filing Summary & Sentiment
File numbers found in text: 024-11229
Letter
Via Edgar Securities and Exchange Commission Re: Fisher Wallace Laboratories, Inc. Offering Statement on Form 1-A Submitted January 17, 2023, as Amended File No. 024-11229
Dear Mr. Ritchie:
On behalf of our client, Fisher Wallace Laboratories, Inc., we hereby request qualification of the above-referenced offering statement at 6 a.m., Eastern Time, on February 24, 2023, or as soon thereafter as is practicable.
If you should require any additional information or clarification, please do not hesitate to contact me at 949-887-8877.
Very truly yours,
/Jeffrey S. Marks/
Show Raw Text
CORRESP
1
filename1.htm
Jeffrey S. Marks, Esq.
9 Chatelaine
Newport Coast, California 92657
(949) 887-8877
February 22, 2023
Via Edgar
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549-7410
Attn: Ben Ritchie
Re:
Fisher Wallace Laboratories, Inc.
Offering Statement on Form 1-A Submitted January 17, 2023, as Amended
File No. 024-11229
Dear Mr. Ritchie:
On behalf of our client, Fisher Wallace Laboratories,
Inc., we hereby request qualification of the above-referenced offering statement at 6 a.m., Eastern Time, on February 24, 2023, or as
soon thereafter as is practicable.
If you should require any additional information
or clarification, please do not hesitate to contact me at 949-887-8877.
Very truly yours,
/Jeffrey S. Marks/
Jeffrey S. Marks